With a distinguished career in finance, Robert F. Hall has established himself as a prominent investment banker and corporate strategist. He has played a pivotal role in advising major corporations on mergers, acquisitions, and strategic initiatives across various sectors. His deep expertise lies in navigating complex financial landscapes, ensuring optimal outcomes for stakeholders involved in large-scale transactions. Recognized for his leadership skills and extensive industry connections, he serves as a trusted advisor to executive teams looking to capitalize on growth opportunities or implement transformative changes within their organizations.
With a distinguished career in finance, Robert F. Hall has established himself as a prominent investment banker and corporate strategist. He has played a pivotal role in advising major corporations on mergers, acquisitions, and strategic initiatives across various sectors. His deep expertise lies in navigating complex financial landscapes, ensuring optimal outcomes for stakeholders involved in large-scale transactions. Recognized for his leadership skills and extensive industry connections, he serves as a trusted advisor to executive teams looking to capitalize on growth opportunities or implement transformative changes within their organizations.
With a focus on operational efficiency, Robert F. Hall leverages his extensive experience in investment banking to drive value creation for client organizations. His strategic insight into market dynamics positions him uniquely to identify transformative opportunities that align with corporate objectives. Prioritizing strong stakeholder relationships, he adeptly navigates complex deal structures and market negotiations, fostering optimal collaboration among all parties involved. This hands-on approach has proven effective in guiding firms through significant growth phases while enhancing overall financial performance.
With a focus on operational efficiency, Robert F. Hall leverages his extensive experience in investment banking to drive value creation for client organizations. His strategic insight into market dynamics positions him uniquely to identify transformative opportunities that align with corporate objectives. Prioritizing strong stakeholder relationships, he adeptly navigates complex deal structures and market negotiations, fostering optimal collaboration among all parties involved. This hands-on approach has proven effective in guiding firms through significant growth phases while enhancing overall financial performance.
| Trades 3089 | Longs Won 2305/3089 74% | Profit Factor 11.61 |
| Profitability | Shorts Won 0/0 0% | Standard Deviation $617,971.05 |
| Average Win $124,838.43 | Best Trade (Sep 03) $25.46M | Sharpe Ratio -9.19 |
| Average Loss -$31,613.92 | Worst Trade (Mar 31) -$1.63M | Z-Score 14.85 (100%) |
| Commissions $0 | Avg. Trade Length 4y 11m 1w 3d | Expectancy $85,130.33 |
| Loss Size | 100% | 90% | 80% | 70% | 60% | 50% | 40% | 30% | 20% | 10% |
| Probability of Loss | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% |
| Consecutive Losing Trades | 16,949 | 15,254 | 13,559 | 11,864 | 10,169 | 8,475 | 6,780 | 5,085 | 3,390 | 1,695 |
| Symbol | Quantity | Cost | Value | Comm. | Profit ($) | Gain (%) | Change |
|---|---|---|---|---|---|---|---|
| 2644 26441C204 | 5,913 | $424.69 | $493 | - | $68.31 | 16.08% | 0.0 |
AAPL Apple Inc. | 68,923 | $5.15M | $21.09M | - | $15.93M | 309.28% | +0.219% |
ABBV AbbVie Inc. | 62,288 | $4.52M | $15.54M | - | $11.02M | 243.79% | -0.546% |
ABT Abbott Laboratories | 65,435 | $3.64M | $7.28M | - | $3.64M | 99.92% | -0.022% |
ADI Analog Devices, Inc. | 1,000 | $318,140 | $389,390.01 | - | $71,250.01 | 22.4% | +2.157% |
ADP Automatic Data Processing Inc. | 57,759 | $5.45M | $15.77M | - | $10.31M | 189.17% | -1.18% |
AEP American Electric Power Company, Inc. | 6,800 | $591,595.24 | $854,046 | - | $262,450.76 | 44.36% | +0.171% |
AKRE Akre Focus ETF | 14,321 | $938,168.71 | $853,531.6 | - | -$84,637.11 | -9.02% | -0.947% |
AMD Advanced Micro Devices, Inc. | 460 | $267,218.59 | $236,610.2 | - | -$30,608.39 | -11.45% | +6.493% |
AMGN Amgen Inc. | 3,191 | $552,104.32 | $1.32M | - | $772,830.76 | 139.98% | -0.629% |
AMZN Amazon.com Inc | 16,107 | $2.23M | $4.23M | - | $2M | 89.35% | -0.932% |
APH Amphenol Corporation | 4,744 | $209,115.52 | $198,050.15 | - | -$11,065.37 | -5.29% | +0.748% |
AVGO Broadcom Inc. | 4,230 | $585,126.04 | $1.66M | - | $1.08M | 184.14% | -5.928% |
AXP American Express Company | 9,239 | $1.52M | $3.16M | - | $1.64M | 107.84% | -0.355% |
BAC Bank of America Corporation | 28,819 | $887,276.17 | $1.86M | - | $971,261.14 | 109.47% | +0.624% |
BAX Baxter International Inc. | 7,345.59 | $541,486.06 | $196,347.62 | - | -$345,138.44 | -63.74% | -1.183% |
BDX Becton, Dickinson and Company | 5,867.1 | $646,738.73 | $1.08M | - | $429,404.75 | 66.4% | +0.797% |
BE Bloom Energy Corporation | 830 | $112,456.7 | $190,933.19 | - | $78,476.49 | 69.78% | -2.616% |
BMO Bank of Montreal | 315 | $22,279.95 | $58,530.15 | - | $36,250.2 | 162.7% | +0.896% |
BMY Bristol-Myers Squibb Company | 51,588 | $3.27M | $3.29M | - | $25,259.33 | 0.77% | -1.237% |